Atlas Trials

Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women

Clinical trial NCT06776055 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06776055
Sponsor
Shanghai Zerun Biotechnology Co.,Ltd
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Cervical CancerVulvar CancerVaginal CancerCIN - Cervical Intraepithelial NeoplasiaHuman Papillomavirus Infection
Start date
2023-03-27
Primary completion
2025-06-01
Enrollment
5372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.